Related Experiment Video

Updated: May 15, 2026

A New Technique for Treating Low-risk Prostate Cancer—Super Active Surveillance
05:19

A New Technique for Treating Low-risk Prostate Cancer—Super Active Surveillance

Published on: November 7, 2025

Novel therapies for the treatment of advanced prostate cancer

J M Clarke1, A J Armstrong

  • 1Duke Cancer Institute and the Duke Prostate Center, Department of Medicine, Division of Medical Oncology, Duke University Medical Center, DUMCBox 102002, Durham, NC 27710, USA.

Current Treatment Options in Oncology
|January 17, 2013
PubMed

Insights

Recent advances offer new treatments for metastatic castration-resistant prostate cancer (CRPC). Further research is needed to identify biomarkers for optimizing these promising therapies.

Area of Science:

  • Oncology
  • Urology
  • Cancer Therapeutics

Background:

  • Metastatic castration-resistant prostate cancer (CRPC) treatment has seen significant progress.
  • Novel therapies include chemotherapy, immunotherapy, hormonal agents, and bone-targeting treatments.
  • Numerous agents are in early-phase clinical trials for advanced prostate cancer.

Purpose of the Study:

  • To review recent advancements in CRPC treatment.
  • To highlight novel therapeutic strategies targeting prostate tumor biology.
  • To emphasize the need for predictive and prognostic biomarkers.

Main Methods:

  • Review of recent clinical trials and research findings in advanced prostate cancer.
  • Analysis of novel therapeutic targets including androgen signaling, intracellular pathways, epigenetics, and cancer immunology.
  • Exploration of the role of prostate cancer genome characterization.

Main Results:

  • Significant successes achieved with novel chemotherapeutics, immunotherapies, hormonal therapies, and bone microenvironment agents.
  • Emerging therapies target key aspects of prostate cancer biology, including androgen signaling, oncogenic pathways, epigenetics, and immunology.
  • Genomic characterization offers potential for exploiting genetic alterations to enhance targeted therapy efficacy.

Conclusions:

  • The landscape of CRPC treatment is rapidly evolving with promising new therapeutic options.
  • Targeting specific molecular pathways and leveraging genomic insights are key strategies.
  • Development of predictive and prognostic biomarkers is crucial for maximizing treatment efficacy and patient safety.

More Related Videos

A Bioluminescent and Fluorescent Orthotopic Syngeneic Murine Model of Androgen-dependent and Castration-resistant Prostate Cancer07:25

A Bioluminescent and Fluorescent Orthotopic Syngeneic Murine Model of Androgen-dependent and Castration-resistant Prostate Cancer

Published on: March 6, 2018

Proton Therapy Delivery and Its Clinical Application in Select Solid Tumor Malignancies08:34

Proton Therapy Delivery and Its Clinical Application in Select Solid Tumor Malignancies

Published on: February 6, 2019

Related Concept Videos

Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
Cancer Therapies02:49

Cancer Therapies

Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
Cancer Therapies02:49

Cancer Therapies

Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
Tumor Immunotherapy01:27

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
Cancer Vaccines01:30

Cancer Vaccines

Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...